Clinical trial for Pancreatic Ductal Adenocarcinoma (PDAC)
Official title Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life
ClinicalTrials.gov ID: NCT07255001
What this study is testing
- What it's testing
- The goal of this clinical trial is to measure hand grip strength in adults with pancreatic ductal adenocarcinoma (PDAC). The main questions it aims to answer are: Is it feasible to measure hand grip strength as part of a clinic visit?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older.
- Histological and/or radiological diagnosis of resectable, non-resectable, or metastatic PDAC. For resectable PDAC, adjuvant setting only.
- ECOG performance status 0-2.
- Life expectancy greater than 6 months as judged by the investigator.
- Planned for treatment, either as part of routine care or in combination with an investigational agent within another study.
You likely can't join if
- Individuals with CT imaging performed outside of Vancouver, BC, Canada.
- Individuals who are unfit to undergo CT imaging of the third lumbar vertebra (L3).
- Individuals who are currently participating in a structured moderate intensity resistance training program.
- Individuals who are otherwise judged by the investigator to be unfit to proceed with this protocol.
- Unable to comply with study assessments and follow-up.
See the full eligibility criteria
- Age 18 years or older.
- Histological and/or radiological diagnosis of resectable, non-resectable, or metastatic PDAC. For resectable PDAC, adjuvant setting only.
- ECOG performance status 0-2.
- Life expectancy greater than 6 months as judged by the investigator.
- Planned for treatment, either as part of routine care or in combination with an investigational agent within another study.
- Ability to hold a dynamometer with one hand.
- Individuals with CT imaging performed outside of Vancouver, BC, Canada.
- Individuals who are unfit to undergo CT imaging of the third lumbar vertebra (L3).
- Individuals who are currently participating in a structured moderate intensity resistance training program.
- Individuals who are otherwise judged by the investigator to be unfit to proceed with this protocol.
- Unable to comply with study assessments and follow-up.
The study team makes the final eligibility decision.
Where it's taking place
- Vancouver, British Columbia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vancouver, British Columbia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.